Perrigo Company plc

PRGO ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $678.7M $622.3M $417.8M $799.5M $779.9M $602.5M $310.1M
Accounts Receivable $1.13B $1.18B $1.19B $931.5M $651.9M
Inventory $806.9M $795.0M $898.7M $629.9M $703.9M
Total Current Assets $2.82B $2.81B $2.79B $2.55B $2.24B
Property, Plant & Equipment $833.1M $870.1M $886.2M $779.9M $681.4M $578.4M
Goodwill $4.18B $4.05B $5.15B $3.47B $1.09B $777.8M
Intangible Assets (Excl. Goodwill) $4.75B $4.53B $5.62B $7.46B $1.56B
Total Assets $11.63B $13.87B $19.35B $13.88B $5.34B
Liabilities
Accounts Payable $450.2M $471.7M $555.8M $364.3M $382.0M
Total Current Liabilities $1.44B $1.84B $2.55B $1.07B $749.4M
Long-Term Debt $3.27B $5.22B $4.97B $3.06B $1.93B
Total Liabilities $5.46B $7.91B $9.24B $5.16B $3.02B
Stockholders' Equity
Retained Earnings $-1.98B $-2.10B $1.98B $1.90B $1.72B
Total Stockholders' Equity $6.17B $5.96B $10.11B $8.72B $2.33B $1.85B $1.53B
← Newer Page 2 of 2 Older →